Valuation: EUROAPI

Market Cap 77.95M 87.17M 72.12M 65.3M 122M 8.29B 124M 868M 343M 4.34B 327M 320M 13.74B P/E 2026 *
-0.62x
P/E 2027 * -1.45x
Enterprise Value 133M 149M 123M 112M 209M 14.17B 212M 1.48B 587M 7.41B 559M 547M 23.47B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.24x
Free-Float
64.75%
Yield 2026 *
-
Yield 2027 * -
1 day+3.03%
1 week+7.51%
Current month+12.71%
1 month+9.09%
3 months-33.66%
6 months-36.15%
Current year-64.05%
1 week 0.74
Extreme 0.742
0.83
1 month 0.71
Extreme 0.713
0.83
Current year 0.71
Extreme 0.713
2.28
1 year 0.71
Extreme 0.713
3.39
3 years 0.71
Extreme 0.713
7.02
5 years 0.71
Extreme 0.713
19.02
10 years 0.71
Extreme 0.713
19.02
Manager TitleAgeSince
Chief Executive Officer - 2024-12-08
Director of Finance/CFO - 2024-10-16
Compliance Officer - 2023-11-26
Director TitleAgeSince
Director/Board Member 62 2022-05-05
Director/Board Member - 2022-05-05
Chairman 57 2024-12-08
Date Insider Type Main position Quantity % Market Cap. Importance
6/1/23 Buy

Chief Financial Officer

617 0.0007%
6/1/23 Buy

Chief Financial Officer

620 0.0007%
6/1/23 Buy

Chief Financial Officer

617 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+3.03%+7.51%-74.94%-82.54% 87.17M
+0.45%+3.13%+54.96%+125.16% 1,140B
+0.94%+4.93%+39.86%+78.72% 641B
+0.39%+1.44%+25.77%+97.48% 507B
+1.43%+4.31%+46.20%+67.12% 383B
-3.21%-2.10%+60.72%+33.22% 347B
-0.41%+2.64%+22.48%+49.82% 293B
+0.23%+3.66%+2.57%+23.69% 266B
+1.22%+4.63%+52.40%+64.85% 240B
+1.70%+3.67%+31.21%+102.15% 197B
Average +0.55%+3.26%+26.12%+55.97% 401.39B
Weighted average by Cap. +0.44%+2.86%+41.36%+83.80%

Financials

2026 *2027 *
Net sales 748M 837M 692M 627M 1.17B 79.61B 1.19B 8.33B 3.3B 41.64B 3.14B 3.07B 132B 748M 836M 692M 626M 1.17B 79.54B 1.19B 8.32B 3.29B 41.6B 3.14B 3.07B 132B
Net income -125M -139M -115M -104M -195M -13.25B -198M -1.39B -548M -6.93B -523M -511M -21.94B -53.63M -59.98M -49.62M -44.92M -84.08M -5.71B -85.46M -597M -236M -2.98B -225M -220M -9.45B
Net Debt 55.24M 61.77M 51.1M 46.27M 86.6M 5.88B 88.02M 615M 243M 3.07B 232M 227M 9.73B 105M 117M 96.99M 87.81M 164M 11.15B 167M 1.17B 462M 5.83B 440M 431M 18.47B
Projected Income Statement - Annual - EUROAPI
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
26-10-26 €0.8160 +3.03% 265,562
26-10-23 €0.7920 +1.15% 369,436
26-10-22 €0.7830 +2.76% 211,261
26-10-21 €0.7620 +1.74% 61,843
26-10-20 €0.7490 -1.32% 115,506
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - EUROAPI
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
0.8160EUR
Average target price
1.000EUR
Spread / Average Target
+22.55%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - EUROAPI
  1. Stock Market
  2. Stocks
  3. EAPI Stock